Welcome to our dedicated page for Bio Green Med Solution news (Ticker: BGMS), a resource for investors and traders seeking the latest updates and insights on Bio Green Med Solution stock.
Bio Green Med Solution, Inc. (NASDAQ: BGMS, BGMSP) publishes regular updates through press releases and SEC filings that cover its evolving business focus and capital markets activity. The company describes itself as a diversified business engaged primarily in fire safety protection and distribution activities, following its acquisition of FITTERS Sdn. Bhd., a Malaysia-based group specializing in fire protection products and services. News related to this transition includes disclosures of product revenue from the sales and distribution of fire safety equipment.
Investors following BGMS news can review announcements about corporate transactions and strategic changes. Recent communications have detailed the company’s shift away from its former role as a clinical-stage biopharmaceutical company, including the liquidation of its UK subsidiary, Cyclacel Limited, and the sale of patent rights related to plogosertib, a PLK1 inhibitor for advanced cancers and hematological malignancies. These items provide context on how the company has reoriented its operations and asset base.
Company news also highlights capital structure and listing-related developments. Examples include the implementation of a one-for-fifteen reverse stock split of its common stock to address Nasdaq bid price requirements, Warrant Exchange Agreements in which existing warrants were exchanged for newly issued common shares, and a Nasdaq notice regarding the market value of publicly held shares for its 6% Convertible Exchangeable Preferred Stock. In addition, board changes, committee appointments, and preferred stock dividend declarations are reported in detail.
This news page allows readers to track Bio Green Med Solution, Inc.’s press releases and related regulatory disclosures in one place, providing a view of its business transition, governance updates, and equity market actions over time.
Bio Green Med Solution (NASDAQ: BGMS) reported Q3 results for the period ended September 30, 2025 and provided a business update.
Key facts: cash and cash equivalents of $3.8M (up from $3.1M at 12/31/24); estimated cash runway into the first quarter of 2026; net loss of $1.0M for Q3 2025 versus $2.0M a year earlier; product revenue from fire safety sales of $81k and cost of sales of $64k following the September acquisition of Fitters Sdn. Bhd.; R&D expense of $0 in Q3 2025 after liquidation of the UK subsidiary.
Corporate actions: a 1-for-15 reverse stock split effective July 7, 2025; sale of Plogosertib-related patents for $300k plus up to $170k in potential milestone payments; Fitters exchange resulted in Fitters owning approximately 19.99% of BGMS; two warrant exchange transactions converted warrants into an aggregate of 1,962,000 new shares.